These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 32826925)
21. PLK1 expression and BI 2536 effects in childhood acute lymphoblastic leukemia. Oliveira JC; Pezuk JA; Brassesco MS; Morales AG; Queiroz RG; Scrideli CA; Tone LG Pediatr Blood Cancer; 2014 Jul; 61(7):1227-31. PubMed ID: 24519995 [TBL] [Abstract][Full Text] [Related]
22. Therapy response correlates with ALDH activity in ALDH low-positive childhood acute lymphoblastic leukemias. Ahlers J; Witte KE; Schwarze CP; Lang P; Handgretinger R; Ebinger M Pediatr Hematol Oncol; 2014 May; 31(4):303-10. PubMed ID: 24308780 [TBL] [Abstract][Full Text] [Related]
23. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia. Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372 [TBL] [Abstract][Full Text] [Related]
24. Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma. Kao YC; Lee SW; Lin LC; Chen LT; Hsing CH; Hsu HP; Huang HY; Shiue YL; Chen TJ; Li CF Tumour Biol; 2013 Apr; 34(2):759-68. PubMed ID: 23208675 [TBL] [Abstract][Full Text] [Related]
25. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome. Yoshii Y; Furukawa T; Oyama N; Hasegawa Y; Kiyono Y; Nishii R; Waki A; Tsuji AB; Sogawa C; Wakizaka H; Fukumura T; Yoshii H; Fujibayashi Y; Lewis JS; Saga T PLoS One; 2013; 8(5):e64570. PubMed ID: 23741342 [TBL] [Abstract][Full Text] [Related]
26. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation. Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662 [TBL] [Abstract][Full Text] [Related]
28. Ginger Phytochemicals Inhibit Cell Growth and Modulate Drug Resistance Factors in Docetaxel Resistant Prostate Cancer Cell. Liu CM; Kao CL; Tseng YT; Lo YC; Chen CY Molecules; 2017 Sep; 22(9):. PubMed ID: 28872603 [TBL] [Abstract][Full Text] [Related]
29. SUMOylation Protects FASN Against Proteasomal Degradation in Breast Cancer Cells Treated with Grape Leaf Extract. Floris A; Mazarei M; Yang X; Robinson AE; Zhou J; Barberis A; D'hallewin G; Azara E; Spissu Y; Iglesias-Ara A; Orrù S; Tomasi ML Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244364 [TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death. Roderick JE; Gallagher KM; Murphy LC; O'Connor KW; Tang K; Zhang B; Brehm MA; Greiner DL; Yu J; Zhu LJ; Green MR; Kelliher MA Blood; 2021 Jan; 137(4):500-512. PubMed ID: 33507291 [TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia. Serafin V; Capuzzo G; Milani G; Minuzzo SA; Pinazza M; Bortolozzi R; Bresolin S; Porcù E; Frasson C; Indraccolo S; Basso G; Accordi B Blood; 2017 Dec; 130(25):2750-2761. PubMed ID: 29101238 [TBL] [Abstract][Full Text] [Related]
32. Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs. Blancafort A; Giró-Perafita A; Oliveras G; Palomeras S; Turrado C; Campuzano Ò; Carrión-Salip D; Massaguer A; Brugada R; Palafox M; Gómez-Miragaya J; González-Suárez E; Puig T PLoS One; 2015; 10(6):e0131241. PubMed ID: 26107737 [TBL] [Abstract][Full Text] [Related]
33. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia. Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824 [TBL] [Abstract][Full Text] [Related]
34. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines. Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433 [TBL] [Abstract][Full Text] [Related]
35. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. Zhou F; Thompson EB Mol Endocrinol; 1996 Mar; 10(3):306-16. PubMed ID: 8833659 [TBL] [Abstract][Full Text] [Related]
36. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416 [TBL] [Abstract][Full Text] [Related]
37. Ginger (Zingiber officinale) phytochemicals-gingerenone-A and shogaol inhibit SaHPPK: molecular docking, molecular dynamics simulations and in vitro approaches. Rampogu S; Baek A; Gajula RG; Zeb A; Bavi RS; Kumar R; Kim Y; Kwon YJ; Lee KW Ann Clin Microbiol Antimicrob; 2018 Apr; 17(1):16. PubMed ID: 29609660 [TBL] [Abstract][Full Text] [Related]
38. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway. Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148 [TBL] [Abstract][Full Text] [Related]
39. Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells. Carlet M; Janjetovic K; Rainer J; Schmidt S; Panzer-Grümayer R; Mann G; Prelog M; Meister B; Ploner C; Kofler R BMC Cancer; 2010 Nov; 10():638. PubMed ID: 21092265 [TBL] [Abstract][Full Text] [Related]
40. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype. Steinbach D; Wittig S; Cario G; Viehmann S; Mueller A; Gruhn B; Haefer R; Zintl F; Sauerbrey A Blood; 2003 Dec; 102(13):4493-8. PubMed ID: 12816874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]